Welcome to ABX-CRO

The independent full-service CRO for cutting-edge research in neuroscience, oncology and molecular imaging. With a unique translational medicine approach, we are happy to develop your product from bench to bedside.

QDOSE

News

Phase 2 study for improvement of prostate cancer diagnosis

Prostate cancer awareness month may already be over, but men's health remains an important topic. We are therefore most pleased to announce that ABX-CRO was chosen to collaborate with Curasight in a phase 2 study to improve the diagnosis of prostate cancer. The...

TRP EU in December 2023

We are happy to announce that our last conference this year will be the Targeted Radiopharmaceuticals Summit Europe. Come and find us in Berlin from 5 to 7 December. Join us for our talks: “Using multiple legislations to optimise clinical trial conduct (EU & USA)”...

ABX-CRO announces the opening of ABX-CRO India at EANM’23

Indian scientists led the way to today´s nuclear medicine: Suresh Srivastava: Fundamental 99mTechnetium generator technology and labelling Nagichettiar Satyamurthy: 18F-labelling methodology & molecular pharmacology Shrikant Deshpande: DOTA as chelator for...

ABX-CRO at EANM’23

On to the next congress – from September 9-13 we will head to Vienna to be part of the 36th Annual Congress of the European Association of Nuclear Medicine – the EANM'23. The EANM industrial exhibition gives an extensive overview of the latest achievements in...

TRP US 2023 and AGRR

After returning from a successful SNMMI in Chicago, we are now excited to participate in the second Targeted Radipharmaceuticals Summit US - the TRP US. Moritz Kallerhoff, ABX-CRO INC.'s Chief Executive Officer, will be on site for us in Boston from July 25-27 to...

ABX-CRO goes SNMMI 2023

Once again we will be attending the premier event for education, science, research and networking in nuclear medicine and molecular imaging - SNMMI 2023 - you will find us in Chicago, Illinois, June 24-27, Booth #3082. We have been an almost annual attendee of this...

Andreas Fintelmann visiting iSRS23

Our General Manager Andreas Fintelmann is heading to Honolulu in May to attend the 25th iSRS conference. From 22-25.5. there will be an outstanding collection of plenaries and workshops. A great opportunity to reactivate old connections and make new ones while in the...

ABX-CRO at TRP 2022

Meet ABX-CRO executives at the TRP 2022 Annual Meeting December 6-8 | Amsterdam. Join us for our presentation about taking Radipharmaceuticals to their next evulitionary level.

ABX-CRO at SNMMI 2022

Meet ABX-CRO executives at the SNMMI 2022 Annual Meeting June 11-14 | Vancouver, BC, at booth no. # 649. Celebrate with us our inauguration of our Boston-based US branch ABX-CRO Inc., further strengthening our global operations, and see the latest version of QDOSETM,...

Andreas Fintelmann joins ABX-CRO as Managing Director

Andreas Fintelmann, leading radiopharmaceutical and precursor industry expert and executive joins ABX-CRO as managing director to support the further global expansion and growth of ABX-CRO. Andreas Fintelmann states “I am...
Brain Perfusion or CT scan of Blood flow in the brain 3d rendering image on the screen with CT Scan room.

Expertise

With more than 20 years of experience in radiopharmaceuticals and molecular imaging, we provide solutions for radiolabelling, dosimetry, regulatory issues and the intricacies of functional imaging that are frequently seen as major obstacles in the conduct of oncology and imaging trials.

Hand turning knob to select phases of clinical trial.

Services

Our unique team of scientists and non-clinical as well as clinical research experts is there to support the development of your medicinal product or device from concept to market.

Hand turning knob to select phases of clinical trial.
Image of the human brain with the pathology

Imaging

Our dedicated Molecular and Functional Imaging Core Lab provides comprehensive turn-key solutions covering all aspects of pre-clinical and clinical Imaging and dosimetry.

Cell

Company

ABX-CRO is an independent international CRO providing standard & specialised clinical and non-clinical studies, with emphasis on neuroscience, oncology and diagnostic imaging. With a unique translational medicine approach, we are happy to develop your product from first non-clinical to late-stage multicentre human studies, or to support your marketing authorisation.

Cell
Close up of examining of test sample under the microscope in laboratory.

Looking for a job?

Do you want to be part of a team developing cutting-edge therapies and imaging solutions?
Do you want to work in a family-friendly company offering flexible solutions to suit your work-life balance?